allogene therapeutics - SERP Analysis

https://allogene.com/

https://finance.yahoo.com/quote/ALLO/

https://www.linkedin.com/company/allogene-therapeutics

https://www.fiercebiotech.com/biotech/allogene-lays-28-staff-extend-runway-amid-delays-car-t-updates

https://www.biospace.com/employer/1918872/allogene-therapeutics

https://finance.yahoo.com/news/allogene-therapeutics-report-first-quarter-123000295.html

https://pitchbook.com/profiles/company/227304-64

https://www.annualreports.com/Company/allogene-therapeutics-inc

https://seekingalpha.com/article/4790445-allogene-therapeutics-still-looking-shaky-but-looking-to-turn-the-corner

https://therisefund.com/portfolio/allogene-therapeutics

https://www.reddit.com/r/wallstreetbets/comments/155wfxm/allogene_therapeutics_allo_potential/

https://www.lupus.org/news/allogene-therapeutics-allo329-receives-fda-fast-track-designation-for-three-autoimmune

https://www.thepharmaletter.com/ones-to-watch/allogene-therapeutics

https://www.biopharmadive.com/news/allogene-arbor-gene-editing-autoimmune-disease-cell-therapy/709999/

https://www.crunchbase.com/organization/allogene-therapeutics

https://www.youtube.com/watch?v=hHDGig74cnU

https://www.globaldata.com/company-profile/allogene-therapeutics-inc/

https://www.biopharmadive.com/news/allogene-asco-study-results-car-t-therapy/578797/

https://www.allogenevirtualbooth.com/

https://ascopubs.org/doi/abs/10.1200/JCO-25-00955

https://crisprmedicinenews.com/news/allogene-therapeutics-allo-316-shows-durable-responses-in-advanced-renal-cell-carcinoma/

https://www.bloomberg.com/profile/company/ALLO:US

https://www.fiercebiotech.com/biotech/allogene-taps-notch-therapeutics-for-cell-therapy-s-next-chapter-stem-cell-based-cancer

https://www.onclive.com/view/tivozanib-monotherapy-may-serve-as-effective-second-line-option-in-metastatic-rcc

https://www.sec.gov/Archives/edgar/data/1737287/000173728725000076/0001737287-25-000076-index.htm

https://www.nasdaq.com/articles/all-you-need-know-about-allogene-therapeutics-allo-rating-upgrade-buy

https://crisprtx.com/

https://www.globenewswire.com/news-release/2024/03/12/2844522/0/en/Allogene-Therapeutics-and-Arbor-Biotechnologies-Announce-Global-Gene-Editing-Licensing-Agreement-to-Support-Advancement-of-Next-Generation-Allogeneic-CAR-T-Platform-in-Autoimmune-D.html

https://www.onclive.com/view/allo-316-produces-responses-in-heavily-pretreated-clear-cell-renal-carcinoma

https://fox59.com/business/press-releases/globenewswire/9384640/allogene-therapeutics-expands-strategic-partnership-with-foresight-diagnostics-to-advance-joint-development-activities-outside-the-us-across-europe-uk-canada-and-australia/

https://www.reddit.com/r/wallstreetbets/comments/15h8e6d/250k_yolo_on_allogene_allo_high_si_right_now/

https://wtop.com/news/2025/03/allogene-therapeutics-q4-earnings-snapshot/

https://www.marketwatch.com/investing/stock/allo

https://community.freetrade.io/t/allogene-therapeutics-inc-allo/27656

https://seekingalpha.com/article/4681399-allogene-therapeutics-stock-2024-platform-vision-sings-mid-term-upside

https://www.youtube.com/watch?v=JTd4iZqeR6s

https://www.cnbc.com/quotes/ALLO

https://www.youtube.com/watch?v=RfMiR7dE-bo

https://money.usnews.com/investing/stocks/allo-allogene-therapeutics-inc

https://www.youtube.com/watch?v=eYuqRh3Qb-8

https://www.defenseworld.net/2025/06/25/allogene-therapeutics-inc-nasdaqallo-shares-sold-by-rhumbline-advisers.html

https://qz.com/allogene-therapeutics-q4-earnings-snapshot-1851337055

https://www.defenseworld.net/2025/06/25/allogene-therapeutics-inc-nasdaqallo-receives-8-44-average-price-target-from-brokerages.html

https://stockanalysis.com/stocks/

https://www.nasdaq.com/articles/allogene-therapeutics-allo-upgraded-to-strong-buy:-heres-what-you-should-know

https://www.theglobeandmail.com/investing/markets/stocks/LLY/pressreleases/33020594/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-exelixis-exel-and-abbott-laboratories-abt/

https://www.dailyhealthindustry.it/precision-biosciences-nuova-strada-per-le-terapie-car-t/

https://www.openpr.com/news/4081834/follicular-lymphoma-pipeline-2025-mechanism-of-action-route

https://www.msn.com/en-xl/money/stockdetails/mbio-us-stock/fi-a1xc9c

https://www.businesswire.com/news/home/20250624141646/en/Gene-Editing-Collaboration-RD-and-Licensing-Agreements-Analysis-Report-2025-Gain-Unprecedented-Access-to-Deals-Entered-Into-by-the-Worlds-Leading-Biopharma-Companies---ResearchAndMarkets.com

https://crisprmedicinenews.com/press-release-service/card/gene-editing-collaboration-rampd-and-licensing-agreements-analysis-report-2025-gain-unprecedent/

https://community.freetrade.io/t/allergy-therapeutics-plc-agy/29746

https://maxcyte.com/

https://markets.financialcontent.com/stocks/article/bizwire-2025-6-24-regenerative-medicine-collaboration-and-licensing-agreements-trends-report-2025-analyze-contract-deals-for-better-due-diligence-in-deal-structuring-researchandmarketscom

https://www.cellectis.com/

https://www.openpr.com/news/4079832/car-t-cell-therapy-market-booms-breakthrough-treatments-drive

https://www.facebook.com/groups/646256811788378/posts/660593220354737/

https://www.businesswire.com/news/home/20250623445721/en/In-Vitro-Diagnostic-Collaboration-and-Licensing-Agreements-Analysis-Report-2025-with-Directory-of-289-Deals---Upfront-Milestone-Royalties-Financial-Terms-Company-A-Z-Deal-Type-and-Therapy-Area---ResearchAndMarkets.com

https://x.com/vym2wsGujT84517

https://theptangiabao.com/wp-style/fb88-132/

https://www.investing.com/news/sec-filings/286

https://www.oncologynewscentral.com/multiple-myeloma/talquetamab-teclistamab-combo-yields-deep-durable-responses-for-rrmm-with-emd

https://www.aktiencheck.de/news/Artikel-Allogene_Therapeutics_Aktie_Schiff_schwankt-18719578

https://www.voiceofalexandria.com/news/national_business_news/in-vitro-diagnostic-collaboration-and-licensing-agreements-analysis-report-2025-with-directory-of-289-deals/article_5bc0adbf-1715-516a-9132-412b10d502b0.html

https://www.gii.co.jp/report/bis1753875-diffuse-large-b-cell-lymphoma-market-global.html